Trinity J. Bivalacqua, M.D, Ph.D.

R. Christian B. Evensen Professor
Director of Urologic Oncology
Associate Professor of Urology, Surgery, and Oncology


Address:
600 N. Wolfe Street, Marburg 409
Baltimore, MD 21287

Appointments: 410-955-6100

Office: 443-287-0385

Email: tbivala1@jhmi.edu

Fax: 410-614-3695

Trinity J. Bivalacqua, M.D., Ph.D., is the R. Christian B. Evensen Professor of Urology and Oncology and Director of Urologic Oncology at the James Buchanan Brady Urologic Institute .  He was born in New Orleans, Louisiana and graduated from Tulane University with undergraduate, graduate and medical degrees. He joined the faculty after completing his General Surgery and Urology training at Johns Hopkins Hospital. He also completed an American Urological Association (AUA) Foundation Post-Doctoral Fellowship from the AUA Care Foundation.

Dr. Bivalacqua has an active clinical practice in Urologic Oncology and Sexual Dysfunction. As a member of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Dr Bivalacqua participates in multidisciplinary approaches to the treatment of a variety of genitourinary cancers. He has a special interest in cancers of the prostate and bladder with an emphasis on organ sparing therapies, minimally invasive techniques (nerve-sparing robotic assisted laparoscopic radical prostatectomy and robotic-assisted laparoscopic radical cystectomy) and orthotopic bladder substitution (neobladder). Although he has a busy surgical practice, he maintains an active research portfolio in order to improve outcomes of cancer patients. A major focus of his research lab is development of pre-clinical models of urothelial carcinoma to test systemic and intravesical immunotherapies and nano-particular based chemotherapies. Also, he heads the tissue-engineering lab which focuses on regenerative approaches to enhance autonomic nerve function and development of tissue-engineered urinary tissue with the ultimate goal of production of a neo-urinary conduit and bladder.


Dr. Bivalacqua's basic, translational and clinical research is funded by peer-reviewed awards and he has recently been acknowledged for his accomplishments in research with several grants including a Career Development Award from the National Institute of Health (NIH), Greenberg Bladder Cancer Institute, and the AUA "Rising Star" Award. He also serves on the Scientific Advisory Board of the Bladder Cancer Advocacy Network (BCAN) and a member of the AUA Leadership Program. 




Education


Undergraduate

  
1997

Bachelor of Science, Tulane University, Cell and Molecular Biology

Doctoral/graduate

  

1999 – 2004

Doctor of Medicine and Doctor of Philosophy, Tulane University School of Medicine
Advisors: Philip J. Kadowitz PhD and Wayne J.G. Hellstrom, MD

Postdoctoral

  
2004 – 2005

Johns Hopkins Medical Institution, Department of Surgery  - Intern
Chair: Julie Freischlag MD
2005 – 2007 Johns Hopkins Medical Institution, Department of Urology – Resident
Chair: Alan Partin MD PhD

2007 – 2008

Johns Hopkins Medical Institution, American Urological Association Foundation Astellas Foundation USA Scholars, MD/PhD Fellowship
Advisor: Arthur L. Burnett, MD
2008 – 2009

Johns Hopkins Medical Institution, Department of Urology – Chief Resident
Chair: Alan Partin MD PhD


Publications


Free Access to abstracts at PubMed

Publications

  1. H.C. Champion, C.C. Erickson III, M.L. Simoneaux, T.J. Bivalacqua, W.A. Murphy, D.H. Coy and P.J. Kadowitz.  Proadrenomedullin NH2-Terminal 20 Peptide has cAMP-Mediated Activity in the Mesenteric Vascular Bed of the Cat.  Peptides 17:1379-1387, 1996. 
  2. H.C. Champion, J.A. Santiago, M.A. Czapla, T.J. Bivalacqua, C. Ilgenfritz and P.J. Kadowitz.  Comparison of Responses to T-kinin and Bradykinin in the Mesenteric Vascular Bed of the Cat.  Peptides 18:1357-1364, 1997. 
  3. H.C. Champion, T.J. Bivalacqua, D.G. Lambert, S.M. McWilliams, J.E. Zadina, A.J. Kastin and P.J. Kadowitz.  Endomorphin 1 and 2, the Endogenous µ-Opioid Agonists, Produce Biphasic Changes in Systemic Arterial Pressure in the Cat.  Life Science 63:PL131-PL136, 1998.
  4. H.C. Champion, T.J. Bivalacqua, A. Rauchwarger, S.M. McWilliams, D.B. McNamara and P.J. Kadowitz.  Analysis of Vasodepressor Responses of Nociceptin and Nociceptin Analogs in the Systemic Vascular Bed of the Anesthetized Rabbit In Vivo.  Journal of Cardiovascular Pharmacology and Therapeutics 3:247-252, 1998.
  5. T.J. Bivalacqua, M. Rajasekaran, H.C. Champion, R. Wang, S.C. Sikka, P.J. Kadowitz, and W.J.G. Hellstrom.  The Influence of Castration on Pharmacological Induction of Penile Erection in the Cat.  Journal of Andrology 19:551-557, 1998.
  6. H.C. Champion, T.J. Bivalacqua, R. Wang, W.J.G. Hellstrom and P.J. Kadowitz.  [Tyr1]- Nociceptin and Nociceptin have Similar Naloxone-Insensitive Erectile Activity in the Cat.  Journal of Andrology 19:747-753, 1998. 
  7. H.C. Champion, T.J. Bivalacqua, D.E. Friedman, J.E. Zadina, A.J. Kastin, and P.J. Kadowitz.  Nitric Oxide Mediates Vasodilator Response to Endomorphin 1, but Not Nociceptin/OFQ, in the Hindquarters Vascular Bed of the Rat.  Peptides 19:1595-1602, 1998. 
  8. T.J. Bivalacqua, A. Dalal, D.G. Lambert, H.C. Champion, and P.J. Kadowitz.  Effects of Candesartan and PD 123319 on Responses to Angiotensin II in the Anesthetized Mouse.  Journal of American Society of Nephrology 10:S98-S100, 1999.
  9. H.C. Champion, T.J. Bivalacqua, D.L. Lambert, D.B. McNamara, and P.J. Kadowitz.  Analysis of the Effects of Candesartan on Responses to Angiotensin II in the Hindquarters Vascular Bed of the Cat. Journal of American Society of Nephrology 10:S101-S103, 1999. 
  10. H.C. Champion, T.J. Bivalacqua, D.G. Lambert, D.B. McNamara, and P.J. Kadowitz.  The Influence of Candesartan and PD123319 on Responses to Angiotensin II in the Hindquarters Vascular Bed of the Rat. Journal of American Society of Nephrology 10:S95-S97, 1999. 
  11. H.C. Champion, T.J. Bivalacqua, R. Wang, P.J. Kadowitz, L.K. Keefer, J.E. Saavedra,  Hrabie, P.C. Doherty, and W.J.G. Hellstrom. Induction of Penile Erection by Intracavernosal and Transurethral Administration of Novel Nitric Oxide Donors in the Cat.  Journal of Urology 161:2013-2019, 1999. 
  12. H.C. Champion, T.J. Bivalacqua, F.M. D’Souza, L.A. Ortiz, J.R. Jeter, K. Toyoda, D.D. Heistad, A.L. Hyman, and P.J. Kadowitz.  Gene-Transfer of Endothelial Nitric Oxide Synthase to the Lung of the Mouse In Vivo: Effect of Agonist-Induced and Flow-Mediated Responses.  Circulation Research 84:1422-1432, 1999. 
  13. S.K. Ahuja, T.J. Bivalacqua, J. Case, M.J. Vincent, S.C. Sikka, and W.J.G. Hellstrom.  A Pilot Study Demonstrating Clinical Benefit From Intralesional Interferon Alpha-2b in the Treatment of Peyronie’s Disease.  Journal of Andrology 20:444-448, 1999. 
  14. H.C. Champion, T.J. Bivalacqua, A.L. Hyman, L.J. Ignarro, W.J.G. Hellstrom, and P.J. Kadowitz.  Gene Transfer of Endothelial Nitric Oxide Synthase to the Penis Augments Erectile Responses in the Aged Rat.  Proceedings of the National Academy of Science USA 96:11648-11652, 1999.
  15. H.C. Champion, T.J. Bivalacqua, D.G. Lambert, R.A. Abassi, and P.J. Kadowitz.  Analysis of Vasoconstrictor Responses to Histamine in the Hindquarters Vascular Bed of the Rabbit. American Journal of Physiology 277:R1179-R1187, 1999. 
  16. T.J. Bivalacqua, H.C. Champion, M. Rajasekeran, S.C. Sikka, P.J. Kadowitz, P.C. Doherty, and W.J.G. Hellstrom.  Potentiation of Erectile Response and cAMP Accumulation by Combination of Prostaglandin E1 and Rolipram, a Selective Inhibitor of the Type 4 Phosphodiesterase (PDE 4).  Journal of Urology 162:1848-1855, 1999.  
  17. T.J. Bivalacqua, A. Dalal. H.C. Champion, and P.J. Kadowitz.  Role of AT1 Receptors and Autonomic Nervous System in Mediating Acute Pressor Responses to ANG II in Anesthetized Mice. American Journal of Physiology 277:E838-E847, 1999. 
  18. H.C. Champion, T.J. Bivalacqua, J.E. Zadina, A.J. Kastin, and P.J. Kadowitz.  Vasodilator Responses to the Endomorphin Peptides, But Not Nociceptin/OFQ, Are Mediated by Nitric Oxide Release.  Annals of the New York Academy of Sciences 897:165-172, 1999. 
  19. T.J. Bivalacqua, H.C. Champion, R. Wang, P.J. Kadowitz, P.C. Doherty and W.J.G. Hellstrom.  Feline Penile Erection Induced By Transurethral Administration of Sodium Nitroprusside.  Urological Research 27:432-436, 1999. 
  20. H.C. Champion, T.J. Bivalacqua, K. Toyoda, D.D. Heistad, A.L. Hyman, P.J. Kadowitz.  In Vivo Gene-Transfer of Prepro-Calcitonin Gene-Related Peptide to the Lung Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension in the Mouse.  Circulation 101:923-930, 2000.
  21. T.J. Bivalacqua, E.K. Diner, T.E. Novak, Y. Vohra, S.C. Sikka, H.C. Champion, P.J. Kadowitz, and W.J.G. Hellstrom.  A Rat Model of Peyronie’s Disease Associated with a Decrease in Erectile Activity and an Increase in Inducible Nitric Oxide Synthase Protein Expression.  Journal of Urology 163:1992-1998, 2000.
  22. T.J. Bivalacqua, H.C. Champion, S.K. Purohit, W.A. Murphy, D. H. Coy, P.J. Kadowitz and W.J.G. Hellstrom.  Nitric Oxide-Mediated Erectile Effects of Galantide But Not Galanin In Vivo.  Nitric Oxide: Biology and Chemistry 4:94-102, 2000.
  23. M.K. Shah, S.Y. Hugghins, H.C. Champion, and T.J. Bivalacqua.  New Therapies for Treating Hypertension: What Every Physician Should Know.  Journal of the Louisiana State Medical Society 152:334-344, 2000. 
  24. T.J. Bivalacqua, H.C. Champion, Y. S. Mehta, A. B. Abdel-Mageed, L. J. Ignarro, P. J. Kadowitz, and W. J.G. Hellstrom.  Adenoviral Gene Transfer of Endothelial Nitric Oxide Synthase (eNOS) to the Penis Improves Age-Related Erectile Dysfunction in the Rat.  International Journal of Impotence Research 12:S8-S17, 2000.  
  25. M. Burger, S.C. Sikka, T.J. Bivalacqua, D.J. Lamb, and W.J.G. Hellstrom.  The Effect of Sildenafil on Human Sperm Motion and Function From Normal and Infertile Men.  International Journal of Impotence Research 12:229-234, 2000.  
  26. S. Leungwattanakij, T.J. Bivalacqua, J.J. Caulfield, and W.J.G. Hellstrom.  Evaluation of Cadaveric Pericardium in the Rat for the Surgical Treatment of Peyronie’s Disease.  Urology 56:1075-1080, 2000.
  27. G.E. Stanley, T.J. Bivalacqua, and W.J.G. Hellstrom.  Penile Prosthetic Trends in the Era of Effective Oral Erectogenic Agents.  Southern Medical Journal 93:1153-1156, 2000. 
  28. B.J. DeWitt, A.D. Kaye, I.N. Ibrahim, T.J. Bivalacqua, F.M. D’Souza, R.E. Banister, A. Salamarif, and B.B. Nossaman.  Effects of Protein Kinase C Isozyme Inhibitors on Constrictor Responses in the Feline Pulmonary Vascular Bed.  American Journal of Physiology 280:L50-L57, 2001. 
  29. P.C. Doherty, T.J. Bivalacqua, H.C. Champion, P.J. Kadowitz, B. Greenwood-Van Meerveld, I. Berzetei-Gurske, and W.J.G. Hellstrom.  Direct Effects of Selective Type 5 Phosphodiesterase Inhibitors, Alone or in Combination with other Vasodilators, on Erectile Response in the Cat.  Journal of Urology 165:1004-1009, 2001.  
  30. T.J. Bivalacqua, H.C. Champion, S. Leungwattanakij, Dae Yul Yang, Jae-Seog Hyun, A. B. Abdel-Mageed, S.C. Sikka, P.J. Kadowitz, and W.J.G. Hellstrom.  Evaluation of Nitric Oxide Synthase and Arginase in the Induction of a Peyronie’s-Like Condition in the Rat.  Journal of Andrology 22:497-506, 2001. 
  31. T.J. Bivalacqua, W.J.G. Hellstrom, P.J. Kadowitz, and H.C. Champion.  Increased Expression of Arginase II in Human Diabetic Corpus Cavernosum: Role in Diabetic-Associated Erectile Dysfunction.  Biochemical Biophysical Research Communication 283:923-927, 2001.  
  32. S.C. Sikka, H.C. Champion, T.J. Bivalacqua, R. Wang, M. Rajasekaran, B.B. Aggarwal, and W.J.G. Hellstrom.  Role of Genitourinary Inflammation in Infertility: Detrimental Effect of Lipopolysaccharide (LPS) and Interferon-gamma (IFN-γ) on Human Spermatozoa.  International Journal of Andrology 24:136-141, 2001. 
  33. T.J. Bivalacqua, H.C. Champion, B.J. DeWitt, J. E. Saavedra, J. A. Hrabie, L. K. Keefer, and P. J. Kadowitz.  Analysis of Vasodilator Responses to Novel Nitric Oxide Donors in the Hindquarters Vascular Bed of the Cat.  Journal of Cardiovascular Pharmacology 38:120-129, 2001. 
  34. H.C. Champion, R.L. Pierce, T.J. Bivalacqua, W.A. Murphy, D.H. Coy, and P.J. Kadowitz.  Analysis of Responses to hAmylin, hCGRP, and hADM in Isolated Resistance Arteries From the Mesenteric Vascular Bed of the Rat.  Peptides 22:1427-1434, 2001.
  35. A. Choppin, D.R. Blue, S.S. Hegde, D. Gennevois, S.A. McKinnon, A. Mokatrin, T.J. Bivalacqua, and W.J.G. Hellstrom.  Evaluation of Oral RO-70-0004 an a1A-Adrenoceptor Antagonist for the Treatment of Male Erectile Dysfunction.  International Journal of Impotence Research 13:157-161, 2001. 
  36. S. Leungwattanakij, T.J. Bivalacqua, S. Reddy, and W.J.G. Hellstrom.  Long-Term Follow Up on Use of Pericardial Graft in the Surgical Management of Peyronie’s Disease.  International Journal of Impotence Research 13:183-186, 2001. 
  37. M.K. Shah, T.J. Bivalacqua, H.C. Champion, and P.J. Kadowitz.  Vasodilator Responses to ATP and UTP are cAMP Dependent in the Mesenteric Vascular Bed of the Cat.  Journal of Cardiovascular Pharmacology and Therapeutics 6:287-295, 2001.  
  38. T.J. Bivalacqua, H.C. Champion, A. Abdel-Mageed, P.J. Kadowitz, and W.J.G. Hellstrom.  Gene Transfer Of Prepro-Calcitonin Gene Related Peptide Restores Erectile Function In The Aged Rat.  Biology of Reproduction 65:1371-1377, 2001. 
  39. M.K. Shah, H.C. Champion, T.J. Bivalacqua, and P.J. Kadowitz.  Differential Responses to ATPgammaS in the Mesenteric and Hindlimb Vascular Bed of the Cat.  Life Sciences 69:2561-2571, 2001. 
  40. J.S. Hyun, M. Baig, D.Y. Yang, S. Leungwattanakij, K. Kim, A. Abdel-Mageed, T.J. Bivalacqua, and W.J.G. Hellstrom.  Localization of Peripheral Dopamine D1 and D2 Receptors in Rat and Human Seminal Vesicle.  Journal of Andrology 23:114-120, 2002. 
  41. H.C. Champion, T.J. Bivalacqua, J.E. Zadina, A.J. Kastin, A.L. Hyman, and P.J. Kadowitz.  Role of Nitric Oxide in Mediating Vasodilator Responses to Opioid Peptides in the Rat.  Clinical and Experimental Pharmacology and Physiology 29:229-232, 2002. 
  42. T.J. Bivalacqua, H.C. Champion, D.G. Lambert, and P.J. Kadowitz.  Vasodilator Responses to Adenosine and Hyperemia are Mediated by A1 and A2 Receptors in the Cat Vascular Bed.  American Journal of Physiology 282: R1696-R1709, 2002. 
  43. J.S. Hyun, T.J. Bivalacqua, D.Y. Yang, S. Leungwattanakij, M. Baig, A.Abdel-Mageed, K. Kim, and W.J.G. Hellstrom.  Localization of Peripheral Dopamine D1 and D2 Receptors in Rat Corpus Cavernosum. BJU International 90:105-112, 2002. 
  44. J.S. Armstrong, T.J. Bivalacqua, W. Chamulitratsurnamex, S.C. Sikka, and W.J.G. Hellstrom.  A comparison of the NADPH oxidase in human sperm and white blood cells.  International Journal of Andrology 25:223-229, 2002. 
  45. T.J. Bivalacqua, H.C. Champion, M. K. Shah, B.J. DeWitt, E.W. Inscho, and P.J. Kadowitz. Comparative Responses to a, b-methylene-ATP in Cat Pulmonary, Mesenteric, and Hindlimb Vascular Beds.  Journal of Applied Physiology 93:1287-1295, 2002.  
  46. H.C. Champion, T.J. Bivalacqua, S.S. Greenberg, T.D. Giles, A.L. Hyman, and P.J. Kadowtiz.  Adenoviral Gene Transfer of Endothelial Nitric-Oxide Synthase (eNOS) Partially Restores Normal Pulmonary Arterial Pressure in eNOS-Deficient Mice.  Proceeding of the National Academy of Science USA 99:13248-13253, 2002. 
  47. T.J. Bivalacqua, A.L. Hyman, P.J. Kadowitz, N. Paolocci, D.A. Kass, and H.C. Champion.  Role of Calcitonin Gene-Related Peptide (CGRP) in Chronic Hypoxia-Induced Pulmonary Hypertension in the Mouse.  Influence of Gene Transfer In Vivo.  Regulatory Peptides 108:129-133, 2002. 
  48. S. Das, N. Maulik, D.K. Das, P.J. Kadowitz, and T.J. Bivalacqua.  Cardioprotection with Sildenafil, a Selective Inhibitor of Cyclic 3',5'-monophosphate-specific Phosphodiesterase 5.  Drugs Experimental Clinical Research 28:213-219, 2002.
  49. K. Chitaley, T.J. Bivalacqua, H.C. Champion, M.F. Usta, W.J.G. Hellstrom, T.M. Mills, and R. Clinton-Webb.  Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats.  Biochemical Biophysical Research Communication 298:427-432, 2002. 
  50. H.C. Champion, T.J. Bivalacqua, R.L. Pierce, W.A. Murphy, D.H. Coy, A.L. Hyman, and P.J. Kadowitz.  Responses to Human CGRP, ADM, and PAMP in Human Thymic Arteries.  American Journal of Physiology: Regulatory Integrative Comparative Physiology 284:R531-R537, 2003. 
  51. M. Passarella, M.F. Usta, T.J. Bivalacqua, W.J.G. Hellstrom, and R. Davis.  Testicular-Sparing Surgery: A Reasonable Option in Selected Patients with Testicular Lesions.  BJU International 91:337-340, 2003. 
  52. W.J.G. Hellstrom, J.S. Hyun, L. Human, J.A. Sanabria, T.J. Bivalacqua, and S. Leungwattanakij.  Antimicrobial activity of antibiotic-soaked, Resist trade mark -coated Bioflex.  International Journal of Impotence Research 15:18-21, 2003. 
  53. T.J. Bivalacqua, J.S. Armstrong, J. Biggerstaff, A.B. Abdel-Mageed, P.J. Kadowitz, W.J.G. Hellstrom, and H.C. Champion.  Gene Transfer of Extracellular SOD to the Penis Reduces Superoxide Anion and Improves Erectile Function in Aged Rats.  American Journal of Physiology: Heart and Circulatory Physiology 284:H1408-H1421, 2003. 
  54. S. Leungwattanakij, T.J. Bivalacqua, M.F. Usta, D.Y. Yang, J.S. Hyun, H.C. Champion, A.B. Abdel-Mageed, and W.J.G. Hellstrom.  Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum.  Journal of Andrology 24:239-245, 2003. 
  55. T.J. Bivalacqua, M.F. Usta, H.C. Champion, D. Adams, D.B. McNamara, A.B. Abdel-Mageed, P.J. Kadowitz, and W.J.G. Hellstrom.  Endothelial Nitric Oxide Synthase Gene Therapy Partially Restores NO Synthesis And Erectile Function In Streptozotocin Diabetic Rats.  Journal of Urology 169:1911-1917, 2003. 
  56. S. Leungwattanakij, T.J. Bivalacqua, D.Y. Yang, J.S. Hyun, and W.J.G. Hellstrom.  Comparison of Cadaveric Pericardial, Dermal, Vein and Gort-Tex Grafts for Tunica Albuginea Substitution Using A Rat Model.  BJU International 92:119-124, 2003. 
  57. M.F. Usta, T.J. Bivalacqua, J.Sanabria, I.T. Koksal, K. Moparty, and W.J.G. Hellstrom.  Patient-Partner Satisfaction and Long Term Results After Surgical Treatment for Peyronie’s Disease.  Urology 62:105-109, 2003.    
  58. S.R. Baber, H.C. Champion, T.J. Bivalacqua, A.L. Hyman, and P.J. Kadowitz.  Role of Cyclooxygenase-2 in the Generation of Vasoactive Prostanoids in the Rat Pulmonary and Systemic Vascular Beds.  Circulation 108:896-901, 2003. 
  59. M.F. Usta, T.J. Bivalacqua, D.Y. Yang, A. Ramanitharan, D.R. Sell, A. Viswanathan, V.M. Monnier, and W.J.G. Hellstrom.  The Protective Effect of Aminoguanidine on Erectile Function in Streptozotocin Diabetic Rats.  Journal of Urology 170:1437-1442, 2003. 
  60. W. Deng, T.J. Bivalacqua, N. Chattergoon, A.L. Hyman, J.R. Jeter, and P.J. Kadowitz.  Adenoviral Gene Transfer of Endothelial Nitric Oxide Synthase: High Level Expression in Ex Vivo Expanded Marrow Stromal Cells.  American Journal of Physiology: Cell Physiology 285:C1322-C1329, 2003.    
  61. B. D. Nossaman, P. A. Dabisch, J. T. Liles, S. R. Baber, H. C. Champion, A. D. Kaye, C.J. Feng, M. Anwar, T. J. Bivalacqua, J. A. Santiago, B. J. De Witt, and P. J. Kadowitz.  Peroxynitrite does not impair pulmonary and systemic vascular responses.  Journal of Applied Physiology 96:455-465, 2004. 
  62. M.F. Usta, T.J. Bivalacqua, G.W. Jabren, L. Myers, J. Sanabria, S.C. Sikka, and W.J.G. Hellstrom.  Relationship Between Severity of Penile Curvature and the Presence of Co-Morbidities in Men with Peyronie’s Disease.  Journal of Urology 171:775-779, 2004. 
  63. G. Dang, R. Matern, T.J. Bivalacqua, S.C. Sikka, and W.J.G. Hellstrom.  Intralesional Interferon Alpha-2B Injections for the Treatment of Peyronie’s Disease.  Southern Medical Journal 97:42-46, 2004.
  64. T.J. Bivalacqua, M.F. Usta, H.C. Champion, S. Leungwattanakij, P.A. Dabisch, D.B. McNamara, P.J. Kadowitz, and W.J.G. Hellstrom.  Effect of Combination Endothelial Nitric Oxide Synthase Gene Therapy and Sildenafil on Erectile Function In Diabetic Rats.  International Journal of Impotence Research 16:21-29, 2004.
  65. M.F. Usta, J. Sanabria, T.J. Bivalacqua, and W.J.G. Hellstrom.  Feline Penile Erections Induced By Topical Glans Penis Application Of Combination Alprostadil And SEPA (TOPIGLAN). International Journal of Impotence Research 16:73-77, 2004.
  66. T.J. Bivalacqua, W. Dang, H.C. Champion, W.J.G. Hellstrom, and P.J. Kadowitz.  Gene Therapy Techniques for the Delivery of Endothelial Nitric Oxide Synthase (eNOS) to the Corpora Cavernosa for Erectile Dysfunction.  Methods in Molecular Biology 279:173-186, 2004.  
  67. T.J. Bivalacqua, H.C. Champion, M.F. Usta, S. Cellek, K.Chitaley, R.C. Webb, R.L. Lewis, T.M. Mills, W.J.G. Hellstrom, and P.J. Kadowitz.  RhoA/Rho-Kinase Suppresses Endothelial Nitric Oxide Synthase in the Penis: Mechanism for Diabetes-Associated Erectile Dysfunction.  Proceeding of the National Academy of Science USA 101:9121-9126, 2004.
  68. M.F. Usta, T.J. Bivalacqua, Z. Tokatli, F. Rivera, K.H. Gulkesen, S.C. Sikka, and W.J.G. Hellstrom.  Stratification of Penile Vascular Pathologies in Patients with Peyronie’s Disease and in Men with Erectile Dysfunction: A Comparative Study.  Journal of Urology 172:259-262, 2004.
  69. M.F. Usta, T.J. Bivalacqua, I.T. Koksal, B. Toptas, S. Surmen, and W.J.G. Hellstrom.  The Protective Effect of Aminoguanidine on Erectile Function in Diabetic Rats is Not Related to the Timing of Treatment.  BJU International 94:429-432, 2004. 
  70. W. Deng, T.J. Bivalacqua, N.N. Chattergoon, J.R. Jeter Jr, P.J. Kadowitz.  Engineering ex vivo-expanded marrow stromal cells to secrete calcitonin gene-related peptide using adenoviral vector.  Stem Cells 22:1279-1291, 2004. 
  71. H.C. Champion, T.J. Bivalacqua, E. Takimoto, D.A. Kass, and A.L. Burnett.  Phosphodiesterase-5A Dysregulation in Penile Erectile Tissue is a Mechanism of Priapism.  Proceeding of the National Academy of Science USA 102:1661-1666, 2005.
  72. I.S. Wittstein, D.R. Thiemann, J.A.C. Lima, K.L Baughman, S.P. Schulman, G. Gerstenblith, K.C. Wu, J.J. Rade, T.J. Bivalacqua, and H.C. Champion.  Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress.  New England Journal of Medicine 352:539-548, 2005.
  73. T.J. Bivalacqua, M.F. Usta, M. Kendirci, L. Pradhan, X. Alvarez, H.C. Champion, P.J. Kadowitz, and W.J.G. Hellstrom.  Superoxide Anion Production in the Rat Penis Impairs Erectile Function in Diabetes: Influence of In Vivo Extracellular Superoxide Dismutase Gene Therapy.  The Journal of Sexual Medicine 2:187-198, 2005.   
  74. S.R. Baber, W. Deng, J. Rodriguez, R.G. Master, T.J. Bivalacqua, A.L. Hyman, and P.J.  Kadowitz.  Vasoactive Prostanoids are Generated from Arachidonic Acid by COX-1 and -2 in the Mouse.  American Journal of Physiology: Heart and Circulatory Physiology 289:H1476-1487, 2005.
  75. M. Kendirci, Z. Zsengeller, T.J. Bivalacqua, S. Gur, M.F. Usta, M. Chen, C. Szabo, and W.J.G. Hellstrom.  Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibition Preserves Erectile Function In Rats After Cavernous Nerve Injury.  Journal of Urology 174:2054-2059, 2005.
  76. M.F. Usta, M. Kendirci, S. Gur, N.A. Foxwell, T.J. Bivalacqua, S. Cellek, and W.J.G. Hellstrom.  The Breakdown of Preformed Advanced Glycation End Products Reverses Erectile Dysfunction in Streptozotocin-Induced Diabetic Rats: Preventive Versus Curative Treatment.  Journal of Sexual Medicine 3:242-252, 2006. 
  77. L. Jin, T. Liu, G.A. Lagoda, H.C. Champion, T.J. Bivalacqua, and A.L. Burnett.  Elevated RhoA/Rho-kinase Activity in Aged Rat Penis: Mechanism for Age-Associated Erectile Dysfunction.  FASEB Journal 20:536-538, 2006.
  78. A.L. Burnett, T.J. Bivalacqua, H.C. Champion, and B. Musicki.  Long-Term Oral Phosphodiesterase 5 Inhibitor Therapy Alleviates Recurrent Priapism.  Urology 67:1043-1048, 2006.
  79. A.L. Burnett, T.J. Bivalacqua, H.C. Champion, and B. Musicki.  Feasibility of the Use of Phosphodiesterase Type 5 Inhibitors in a Pharmacologic Prevention Program for Recurrent Priapism.  Journal of Sexual Medicine 3:1077-1084, 2006.
  80. T.J. Bivalacqua, W. Deng, M. Kendirci, M.F. Usta, C. Robinson, B.K. Taylor, S.N. Murthy, H.C. Champion, W.J.G. Hellstrom, and P.J Kadowitz.  Mesenchymal Stem Cells Alone or Ex Vivo Gene-Modified with Endothelial Nitric Oxide Synthase Reverse Age-Associated Erectile Dysfunction.  American Journal of Physiology: Heart and Circulatory Physiology 292:H1278-1290, 2007.
  81. T.J. Bivalacqua, A.L. Burnett, W.J.G. Hellstrom, and H.C. Champion.  Overexpression of Arginase in the Aged Mouse Penis Impairs Erectile Function and Decreases NOS3 Activity: Influence of In Vivo Gene Therapy of Anti-Arginase.  American Journal of Physiology: Heart and Circulatory Physiology 292:H1340-1351, 2007.
  82. L.L. Hsu, H.C. Champion, S.A. Campbell-Lee, T.J. Bivalacqua, E.A. Manci, B.A. Diwan, D.M. Schimel, A.E. Cochard, X. Wang, A.N. Schechter, C.T. Noguchi, and M.T. Gladwin.  Hemolysis In Sickle Cell Mice Causes Pulmonary Hypertension Due To Global Impairment In Nitric Oxide Bioavailability.  Blood 109:3088-3098, 2007.
  83. T.J. Bivalacqua, H.C. Champion, T. Liu, and A.L. Burnett.  Endothelial Nitric Oxide Synthase Keeps Erection Regulatory Function Balance in the Penis.  European Urology 51:1732-1740, 2007.
  84. T.J. Bivalacqua, M. Kendirci, H.C. Champion, W.J.G. Hellstrom, K.E. Andersson, and P. Hedlund.  Dysregulation of cGMP-Dependent Protein Kinase (PKG) Impairs Erectile Function in Diabetes: Influence of In Vivo Gene Therapy of PKG1a.  BJU International 99:1488-1494, 2007.
  85. B.D. Nossaman, T.J. Bivalacqua, H.C. Champion, S.R. Baber and P.J. Kadowitz.  Analysis of Vasodilator Responses to Peroxynitrite in the Hindlimb Vascular Bed of the Cat.  Journal of Cardiovascular Pharmacology 50:358-366, 2007.
  86. T.J. Bivalacqua, E.M. Schaeffer, L. Mettee, A. Wagner, L.M. Su, and C.P. Pavlovich.  Intraperitoneal Effects of Extraperitoneal Laparoscopic Radical Prostatectomy.  Urology 72:273-277, 2008.
  87. T.J. Bivalacqua, T.J. Guzzo, E.M. Schaeffer, M.A. Gebska, H.C. Champion, A.L. Burnett, and M.L. Gonzalgo.  Application of Evicel to Cavernous Nerves of the Rat Does Not Influence Erectile Function In Vivo.  Urology 72:1169-1173, 2008.
  88. T.J. Guzzo, C.G. Rogers, C.Y. Deng, T.J. Bivalacqua, G.S. Palapattu, P.J. Bastian, M.A. Eisenberger, M.P. Schoenberg and M.L. Gonzalgo.  Outcomes of Patients After Aborted Radical Cystectomy for Intraoperative Findings of Metastatic Disease.  BJU International 102:1539-1543, 2008.
  89. A.L. Burnett, M.E. Allaf, and T.J. Bivalacqua.  Erythropoietin Promotes Erection Recovery after Nerve Sparing Radical Retropubic Prostatectomy: A Retrospective Analysis.  Journal of Sexual Medicine 5:2392-2398, 2008.
  90. A.L. Burnett, T.D. Strong, B.J. Trock, L. Jin, T.J. Bivalacqua, and B. Musicki.  Serum Biomarker Measurements of Endothelial Function and Oxidative Stress after Daily Dosing of Sildenafil in Type 2 Diabetic Men with Erectile Dysfunction.  Journal of Urology 181:245-251, 2009.
  91.  T.J. Bivalacqua, T.E. Sussan, T.D. Strong, D.E. Berkowitz, S.S. Biswal, A.L. Burnett, and H.C. Champion.  Sildenafil Inhibits Superoxide Formation And Prevents Endothelial Dysfunction In A Mouse Model Of Second-Hand Cigarette Smoke Induced Erectile Dysfunction.  Journal of Urology 181:899-906, 2009.
  92. B. Musicki, A.E. Ross, H.C. Champion, A.L. Burnett, and T.J. Bivalacqua.  Post-Translation Modification of Constitutive Nitric Oxide Synthase in the Penis.  Journal of Andrology 30:352-362, 2009. 
  93.  T.J. Bivalacqua, B. Musicki, L.L. Hsu, M.T. Gladwin, A.L. Burnett, and H.C. Champion.  Establishment of a Transgenic Sickle Cell Mouse Model to Study the Pathophysiology of Priapism.  Journal of Sexual Medicine 6:2494-2504, 2009.
  94. T.J. Guzzo, T.J. Bivalacqua, P.M. Pierorazio, E.M. Schaeffer, D.Y. Chan, and M.E. Allaf.  Xanthogranulomatous Pyelonephritis: Presentation and Management in the Laparoscopic Era.  BJU International 104:1265-1268, 2009.
  95. T.J. Guzzo, T.J. Bivalacqua, A. Magheli, M.E. Nielsen, F.J. Attenello, M.P. Schoenberg, and M.L. Gonzalgo.  Pathologic Upstaging at the Time of Radical Cystectomy is Associated with Worse Recurrence Free Survival in Patients with BCG Refractory Bladder Cancer. Urology 74:1276-1280, 2009. 
  96. J.H. Kim, L. Bugaj, T.J. Bivalacqua, S. Ryoo, Y.J. Oh, A. Camara, G. Sikka, D. Nyhan, A. Shoukas, H. C. Champion, and D.E. Berkowitz.  Arginase Inhibition Restores NOS Coupling and Reverses Endothelial Dysfunction and Vascular Stiffness in Old Rats.  Journal of Applied Physiology 107:1249-1257, 2009.
  97. T.J. Guzzo, B.K. McNeil, T.J. Bivalacqua, L.J. Sokoll and M.P. Schoenberg.  Circulating Tumor Cells do not Predict Extravesical Disease in Bladder Cancer Patients Prior to Radical Cystectomy.  Urologic Oncology (in press), 2009.
  98. Musicki B, Liu T, Strong TD, Lagoda GA, Bivalacqua TJ, Burnett AL.  Post-translational Regulation of Endothelial Nitric Oxide Synthase (eNOS) by Estrogens in the Rat Vagina. Journal of Sexual Medicine 7:1768-1777, 2010.
  99. Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R.  Priapism: pathogenesis, epidemiology, and management. Journal of Sexual Medicine. 7: 476-500, 2010.
  100. Deng W, Bivalacqua TJ, Champion HC, Hellstrom WJ, Murthy SN, Kadowitz PJ. Gene therapy techniques for the delivery of endothelial nitric oxide synthase to the lung for pulmonary hypertension. Methods Mol Biol. 610:309-321, 2010.
  101. Deng W, Bivalacqua TJ, Champion HC, Hellstrom WJ, Murthy SN, Kadowitz PJ.  Superoxide dismutase - a target for gene therapeutic approach to reduce oxidative stress in erectile dysfunction. Methods Mol Biol. 610: 213-227, 2010.
  102.  Bivalacqua TJ, Ross AE, Strong TD, Gebska MA, Musicki B, Champion HC, Burnett AL.  Attenuated RhoA/Rho-Kinase Signaling in the Penis of Transgenic Sickle Cell Mice.  Urology 76:510-516, 2010.
  103. Gratzke C, Strong TD, Gebska MA, Champion HC, Stief CG, Burnett AL, Bivalacqua TJ.  Activated RhoA/Rho-kinase Impairs Erectile function after Cavernous Nerve Injury in Rats.  Journal of Urology 184: 2197-2204, 2010.
  104.  Pierorazio PM, Guzzo TJ, Han M, Bivalacqua TJ, Epstein JI, Schaeffer EM, Schoenberg M, Walsh PC, Partin AW.  Long term survival after radical prostatectomy for men with high gleason sum in pathologic specimen.  Urology 76:715-721, 2010. 
  105.  Han M, Trock BJ, Partin AW, Humphreys EB, Bivalacqua TJ, Guzzo TJ, Walsh PC.  The impact of preoperative erectile dysfunction on survival after radical prostatectomy. BJU International 106:1612-1617, 2010.
  106.  Cervellione RM, Husmann DA, Bivalacqua TJ, Sponseller PD, Gearhart JP. Penile ischemic injury in the exstrophy/epispadias spectrum: New insights and possible mechanisms. Journal of Pediatric Urology 6:450-456, 2010 
  107. Bivalacqua TJ, Loeb S, Pierorazio PM, Schoenberg MP, Partin AW, Guzzo TJ.  Is Prostate Specific Antigen Surveillance Necessary in Men with Benign Prostate Pathology Following Radical Cystoprostatectomy for Bladder Cancer.  Urologia Internationalis 85:466-469, 2010.
  108.   Musicki B, Champion HC, Hsu LL, Bivalacqua TJ, Burnett AL.  Post-translational inactivation of endothelial nitric oxide synthase in the transgenic sickle cell mouse penis.  Journal of Sexual Medicine 8:419-426, 2011.
  109.  Johnson JM, Bivalacqua TJ, Lagoda GA, Burnett AL, Musicki B.  eNOS-uncoupling in age-related erectile dysfunction.  International Journal of Impotence Research 23:43-49, 2011.
  110. Musicki B, Champion HC, Hsu LL, Bivalacqua TJ, Burnett AL.  Post-translational inactivation of endothelial nitric oxide synthase in transgenic sickle cell mouse penis.  Journal of Sexual Medicine 8:419-426, 2011.
  111.  Gebska MA, Stevenson BK, Hemnes AR, Bivalacqua TJ, Haile A, Hesketh CG, Murray CL, Zaiman AL, Halushka MK, Krongkaew N, Strong TD, Cooke CA, El-Haddad H, Tuder RM, Berkowitz DE, Champion HC.  Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity.  Cardiovascular Pharmacology 90:353-363, 2011.
  112.  Burnett AL, Bivalacqua TJ.  Priapism: new concepts in medical and surgical management.  Urologic Clinics of North America 38:185-194, 2011.
  113.  Gupta AD, Bandari J, Ross AE, McCall CM, Tufaro A, Bivalacqua TJ.  Management of Primary Squamous Cell Carcinoma at the Mucocutaneous Junction of an Ileal Conduit.  Urology 78:1229-31, 2011.
  114. Guzzo TJ, Hockenberry MS, Mucksavage P, Bivalacqua TJ, Schoenberg MP.  Smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center.  Urology 79:166-171, 2012. 
  115. Kutlu O, Ross AE, Schaeffer EM, Gratzke C, Stief CG, Strong TD, Burnett AL, Hedlund P, Bivalacqua TJ.  Increased expression of Nestin, a neural stem cell marker, in the major pelvic ganglion following cavernous nerve injury.  International Journal of Impotence Research 24:84-90, 2012.
  116. Mullins JM, Guzzo TJ, Pierorazio PM, Eifler J, Ball M, Schoenberg MP, Bivalacqua TJ. Stented versus Nonstented Ureteroenteric Anastomosis of Continent and Non-Continent Urinary Diversion after Cystectomy: Effect on Post-operative Morbidity and Stricture Rate.  Urologia Internationalis 88:66-70, 2011.
  117.  Kavalukas SL, Uzgare AR, Bivalacqua TJ, Barbul A.  Arginase inhibition promotes wound healing in mice.  Surgery 151:287-295, 2012.
  118. Guzzo TJ, Resnick MJ, Canter DJ, Bivalacqua TJ, Rosen MA, Bergey MR, Magerfleisch L, Tomazewski JE, Wein AJ, Malkowicz SB. Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance.  Urologic Oncology 30:301-5, 2012.
  119. Calenda G, Strong TD, Pavlovich CP, Schaeffer EM, Burnett AL, Yu W, Davies KP, Bivalacqua TJ.  Whole genome microarray of the major pelvic ganglion after cavernous nerve injury: new insights into molecular profile changes after nerve injury.  BJU International 109:1552-64, 2012.
  120. Gur S, Kadowitz PJ, Sikka SC, Bivalacqua TJ, Hellstrom WJ.  Inhibition of sympathetic neuroeffector transmission in human corpus cavernosum.  BJU International 110:856-62, 2012.
  121. Segal R, Hannan JL, Liu X, Kutlu O, Burnett AL, Champion HC, Kim JH, Steppan J, Berkowitz DE, Bivalacqua TJ.  Chronic Oral Administration of the Arginase Inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) Improves Erectile Function in Aged Rats.  Journal of Andrology 33:1169-1175, 2012.
  122. Segal R, Bivalacqua TJ, Burnett AL.  Losartan to preserve erectile function following radical prostatectomy: a retrospective analysis.  BJU International 110:1782-1786, 2012.
  123. Castiglione F, Bergamini A, Bettiga A, Bivalacqua TJ, Benigni F, Strittmatter F, Gandaglia G, Rigatti P, Montorsi F, Hedlund P.  Perioperative betamethasone treatment reduces signs of bladder dysfunction in a rat model for neuropraxia in female urogenital surgery.  European Urology 62:1076-85, 2012.
  124. Cellek S, Bivalacqua TJ, Burnett AL, Chitaley K, Lin CS. Common Pitfalls in Some of the Experimental Studies in Erectile Function and Dysfunction: A Consensus Article. Journal of Sexual Medicine 9:2770-84, 2012.
  125.  Pierorazio PM, Mullins JK, Eifler JB, Voth K, Hyams ES, Han M, Pavlovich CP, Partin AP, Bivalacqua TJ, Allaf ME, Schaeffer EM.  Contemporaneous comparison of open versus minimally-invasive radical prostatectomy for high risk prostate cancer.  BJU International 112:751-777, 2013. 
  126.   Pierorazio PM, Mullins JK, Hyams ES, Partin AW, Han M, Walsh PC, Schaeffer EM, Pavlovich CP, Allaf ME, Bivalacqua TJ.  Trends in Immediate Perioperative Morbidity and Delay in Discharge Following Radical Prostatectomy: A 20-year Institutional Experience.  BJU International 112:45-53, 2013.
  127. Segal R, Readal N, Pierorazio PM, Burnett AL, Bivalacqua TJ.  Corporal "Snake" Maneuver for the Treatment of Ischemic Priapism: Long Term Followup.  Journal of Urology 189:1025-1029, 2013.
  128.   Mulhall JP, Bivalacqua TJ, Becher E.  Standard Operating Procedures for the Preservation of Erectile Function Outcomes after radical prostatectomy.  Journal of Sexual Medicine 10:195-203, 2013.
  129.   Hannan JL, Albersen M, Kutlu O, Gratzke C, Stief CG, Burnett AL, Lysiak JJ, Hedlund P, Bivalacqua TJ. Inhibition of Rho-kinase Improves Erectile Function, Increases Nitric Oxide Signaling and Decreases Penile Apoptosis in a Rat Model of Cavernous Nerve Injury. Journal of Urology 189:1155-1161, 2013.
  130. Castiglione F, Hedlund P, Van der Aa F, Bivalacqua TJ, Rigatti P, Van Poppel H, Montorsi F, De Ridder D, Albersen M. Intratunical Injection of Human Adipose Tissue-derived Stem Cells Prevents Fibrosis and Is Associated with Improved Erectile Function in a Rat Model of Peyronie's Disease. European Urology 63:551-560, 2013.
  131. Rubio-Aurioles E, Bivalacqua TJ. Standard Operational Procedures for Low Sexual Desire in Men. Journal of Sexual Medicine 10:94-107, 2013.
  132.  Segal RL, Readal N, Pieororazio PM, Kutlu O, Schoenberg M, Bivalacqua TJ.  Radical Cystectomy in Patients with Preexisting Three-Piece Inflatable Penile Prosthesis.  Journal of Sexual Medicine 10:595-598, 2013.
  133. Massanyi EZ, Gupta A, Goel S, Gearhart JP, Burnett AL, Bivalacqua TJ, Redett RJ.  Radial Forearm Free Flap Phalloplasty for Penile Inadequacy in Exstrophy Patients. Journal of Urology 190(suppl 4): 1577-1582, 2013.
  134. Segal RL, Cabrini MR, Harris ED, Mostwin JL, Bivalacqua TJ, Burnett AL.  Combined Inflatable Penile Prosthesis-Artificial Urinary Sphincter Implantation: No Increased Risk of Adverse Events Compared to Single or Staged Device Implantation..  Journal of Urology 190:2183-2188, 2013.
  135.  Pierorazio PM, Gorin MA, Ross AE, Feng Z, Trock BJ, Schaeffer EM, Han M, Epstein JI, Partin AW, Walsh PC, Bivalacqua TJ.  Pathological and Oncologic Outcomes for Men with Positive Lymph Nodes at Radical Prostatectomy: The Johns Hopkins Hospital 30-year Experience.  Prostate 73:1673-1680, 2013.
  136.  Bivalacqua TJ, Pierorazio PM, Ross AE, Allaf ME, Carter BE, Walsh PC.  Anatomical Extent of Lymph Node Dissection:  Impact on Men with Positive Lymph Nodes at Time of Radical Prostatectomy.  Urology 82:653-659, 2013.  
  137. Kaye DR, Hyndman E, Segal RL, Mettee LZ, Trock BJ, Feng Z, Su LM, Bivalacqua TJ, Pavlovich CP.  Urinary outcomes are significantly affected by nerve-sparing quality during radical prostatectomy. Urology 82:1348-1358, 2013.
  138. Gonzalez-Roibon N, Han JS, Lee S, Feng Z, Arslankoz S, Smith N, Pierorazio PM, Humphreys E, Deweese TL, Partin AW, Bivalacqua TJ, Han M, Trock B, Netto GJ.  Comparison of Biochemical Recurrence Free Survival Between Periprostatic and Pelvic Lymph Node Metastases of Prostate Cancer.  International Journal of Surgical Pathology 21:352-7, 2013.
  139.  Pavlovich CP, Levinson AW, Su LM, Mettee LZ, Feng Z, Bivalacqua TJ, Trock BJ.  Nightly vs. on-demand sildenafil for penile rehabilitation after minimally-invasive nerve-sparing radical prostatectomy: Results of a randomized double-blind trial with placebo.  BJU International 112:844-851, 2013.
  140. Bivalacqua TJ, Musicki B, Hsu LL, Berkowitz DE, Champion HC, Burnett AL.  Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress.  PLoS one 2;8:e68028, 2013.
  141. Kinde I, Munari E, Faraj SF, Hruban RH, Schoenberg M, Bivalacqua TJ, Allaf M, Springer S, Wang Y, Diaz LA Jr, Kinzler KW, Vogelstein B, Papadopoulos N, Netto GJ. TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine. Cancer Research 73:7162-7167, 2013.
  142. Albersen M, Berkers J, Dekoninck P, Deprest J, Lue TF, Hedlund P, Lin CS, Bivalacqua TJ, Van Poppel H, De Ridder D, Van der Aa F. Expression of a Distinct Set of Chemokine Receptors in Adipose Tissue-Derived Stem Cells is Responsible for In Vitro Migration Toward Chemokines Appearing in the Major Pelvic Ganglion Following Cavernous Nerve Injury. Sexual Medicine 1:3-15, 2013.
  143. Gorin MA, Kates M, Mullins JK, Pierorazio PM, Schoenberg MP, Bivalacqua TJ.  Impact of Hospital Volume on Perioperative Outcomes and Costs of Radical Cystectomy: Analysis of the Maryland Health Services Cost Review Commission Database.  Canadian Journal of Urology 21:102-107, 2014.  
  144. Kates M,  Gorin MA, Deibert CM, Pierorazio PM, Schoenberg MP, McKiernan JM, Bivalacqua TJ.   In-Hospital Death and Hospital Acquired Conditions Among Patients Undergoing Partial Cystectomy for Bladder Cancer in the United States.  Urologic Oncology 32:53, 2014.
  145.  Sundi D, Wang VM, Pierorazio PM, Han M, Bivalacqua TJ, Ball MW, Antonarakis ES, Partin AW, Schaeffer EM, Ross AE. Very-high-risk localized prostate cancer: definition and outcomes. Prostate Cancer Prostatic Diseases 17:57-63, 2014.
  146.   Musicki B, Bivalacqua TJ, Champion HC, Burnett AL. Sildenafil Promotes eNOS Activation and Inhibits NADPH Oxidase in the Transgenic Sickle Cell Mouse Penis.  J Sexual Medicine 11:424-430, 2014.
  147.   Sundi D, Wang V, Pierorazio PM, Han M, Partin AW, Tran PT, Ross AE, Bivalacqua TJ.  Identification of men with the highest risk of early disease recurrence after radical prostatectomy.  Prostate 74:628-636, 2014.
  148.   Hannan JL, Kutlu O, Stopak BL, Liu X, Castiglione F, Hedlund P, Burnett AL, Bivalacqua TJ. Valproic Acid Prevents Penile Fibrosis and Erectile Dysfunction in Cavernous Nerve-Injured Rats. Journal of Sexual Medicine. 11:1442-1451, 2014.
  149. Hayashi M, Bernert H, Kagohara LT, Maldonado L, Brait M, Schoenberg M, Bivalacqua TJ, Netto GJ, Koch W, Sidransky D, Hoque MO. Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine. Oncotarget. 5:3350-3361, 2014.
  150. Moningi S, Armour EP, Terezakis SA, Efron JE, Gearhart SL, Bivalacqua TJ, Kumar R, Le Y, Kien Ng S, Wolfgang CL, Zellars RC, Ellsworth SG, Ahuja N, Herman JM. High-dose-rate intraoperative radiation therapy: the nuts and bolts of starting a program. Journal of Contemporary Brachytherapy. 6:99-105, 2014.
  151. Gonzalez-Roibon N, Kim JJ, Faraj SF, Chaux A, Bezerra SM, Munari E, Ellis C, Sharma R, Keizman D, Bivalacqua TJ, Schoenberg M, Eisenberger M, Carducci M, Netto GJ. Insulin-like Growth Factor-1 Receptor Overexpression Is Associated With Outcome in Invasive Urothelial Carcinoma of Urinary Bladder: A Retrospective Study of Patients Treated Using Radical Cystectomy. Urology. 83:1444, 2014.
  152.   Segal RL, Cabrini MR, Bivalacqua TJ, Burnett AL. Penile straightening maneuvers employed during penile prosthesis surgery: technical options and outcomes. International Journal of Impotence Research 26:182-5, 2014. 
  153. Segal RL, Massanyi EZ, Gupta AD, Gearhart JP, Redett RJ, Bivalacqua TJ,  Burnett AL. Inflatable penile prosthesis technique and outcomes after radial forearm free flap neophalloplasty. International Journal of Impotence Research (in press). 2014
  154. Faisal FA, Sundi D, Pierorazio PM, Ball MW, Humphreys EB, Han M, Epstein JI, Partin AW, Carter HB, Bivalacqua TJ, Schaeffer EM, Ross AE. Outcomes of men with an elevated PSA as their sole preoperative intermediate or high risk feature. BJU International 114:E120-9, 2014.
  155. Bezerra SM, Lotan TL, Faraj SF, Karram S, Sharma R, Schoenberg M, Bivalacqua TJ, Netto GJ. GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin. Human Pathology 45:1682-7, 2014.
  156. Weyne E, Albersen M, Hannan JL, Castiglione F, Hedlund P, Verbist G, De Ridder D, Bivalacqua TJ, Van der Aa F. Increased Expression of the Neuroregenerative Peptide Galanin in the Major Pelvic Ganglion Following Cavernous Nerve Injury.  Journal of Sexual Medicine 11:1685-93, 2014.
  157. Maldonado L, Brait M, Michailidi C, Munari E, Driscoll T, Schultz L, Bivalacqua TJ, Schoenberg M, Sidransky D, Netto GJ, Hoque MO. An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine. Oncotarget. 2014 5:5218-33, 2014.
  158. Reese AC, Ball MW, Gandhi N, Gorin MA, Netto GJ, Bivalacqua TJ, Schoenberg MP.  The utility of an extensive postchemotherapy staging evaluation in patients receiving neoadjuvant chemotherapy for bladder cancer. Urology. 84:358-63, 2014.
  159. Gordetsky J, Bivalacqua TJ, Schoenberg M, Epstein JI. Ureteral and urethral frozen sections during radical cystectomy or cystoprostatectomy: an analysis of denudation and atypia. Urology. 84:619-23, 2014.
  160. Faraj SF, Chaux A, Gonzalez-Roibon N, Munari E, Ellis C, Driscoll T, Schoenberg MP, Bivalacqua TJ, Shih IeM, Netto GJ. ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder. Human Pathology 45:2233-9, 2014.
  161. Zargar H, Espiritu PN, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Vasdev N, Yu EY, Youssef D, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Garcia  JA, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC.  Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. European Urology 67:241-49, 2015.
  162. Munari E, Chaux A, Maldonado L, Compérat E, Varinot J, Bivalacqua TJ, Hoque MO, Netto GJ. Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection. Histopathology. 66:262-9, 2015.
  163. Tian W, Guner G, Miyamoto H, Cimino-Mathews A, Gonzalez-Roibon N, Argani P, Li X, Sharma R, Subhawong AP, Rezaei K, Bivalacqua TJ, Epstein JI, Bishop JA, Netto GJ. Utility of uroplakin II expression as a marker of urothelial carcinoma.  Human Pathology. 46:58-64, 2015.
  164. Michailidi C, Hayashi M, Datta S, Sen T, Zenner K, Oladeru O, Brait M, Izumchenko E, Baras A, VandenBussche C, Argos M, Bivalacqua TJ, Ahsan H, Hahn NM, Netto GJ, Sidransky D, Hoque MO. Involvement of epigenetics and EMT related miRNA in arsenic induced neoplastic transformation and their potential clinical use.  Cancer Preventative Research (Phila). 8:208-21, 2015.
  165. Bezerra SM, Chaux A, Ball MW, Faraj SF, Munari E, Gonzalez-Roibon N, Sharma R, Bivalacqua TJ, Burnett AL, Netto GJ. Human papillomavirus infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas. Human Pathology. 46:532-40, 2015.
  166. Hannan JL, Albersen M, Stopak B, Liu X, Burnett AL, Hoke M, Bivalacqua TJ.  Temporal changes in neurotrophic factors and neurite outgrowth in the major pelvic ganglion following cavernous nerve injury.  Journal of Neuroscience Research 93:954-63, 2015.
  167. Gandhi NM, Baras A, Munari E, Faraj S, Reis LO, Liu JJ, Kates M, Hoque M, Berman D, Hahn NM, Eisenberger M, Netto GJ, Schoenberg MP, Bivalacqua TJ.  Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes.  Urologic Oncology 33:204.e1-7, 2015.
  168. Faraj SF, Munari E, Guner G, Taube J, Anders R, Hicks J, Meeker A, Schoenberg M, Bivalacqua TJ, Drake C, Netto GJ.  Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma.  Urology 85:703.e1-6, 2015.
  169. Ball MW, Sundi D, Reese AC, Meyer CF, Terezakis SA, Efron JE, Schoenberg MP, Epstein JI, Ahuja N, Bivalacqua TJ. Multimodal Therapy in the Treatment of Prostate Sarcoma: The Johns Hopkins Experience. Clinical Genitourinary Cancer. 13:435-40, 2015.
  170. Rowe SP, Gage KL, Faraj SF, Macura KJ, Cornish TC, Gonzalez-Roibon N, Guner G, Munari E, Partin AW, Pavlovich CP, Han M, Carter HB, Bivalacqua TJ, Blackford A, Holt D, Dannals RF, Netto GJ, Lodge MA, Mease RC, Pomper MG, Cho SY. ¹⁸F-DCFBCPET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer. Journal of Nuclear Medicine. 56:1003-10, 2015.
  171. Dean JD, McMahon CG, Guay AT, Morgentaler A, Althof SE, Becher EF, Bivalacqua TJ, Burnett AL, Buvat J, El Meliegy A, Hellstrom WJ, Jannini EA, Maggi M, McCullough A, Torres LO, Zitzmann M. The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men. Journal of Sexual Medicine 12:1660-86, 2015.
  172.  Lerner SP, Dinney C, Kamat A, Bivalacqua TJ, Nielsen M, O'Donnell M, Schoenberg MP, Steinberg G. Clarification of bladder cancer disease states following treatment of patients with intravesical BCG.  Bladder Cancer 1:29-20, 2015.
  173.  Joice GA, Kates M, Sopko NA, Hannan JL, Bivalacqua TJ. Sickle Cell Disease in Priapism: Disparity in Care? Urology. 86:72-7, 2015.
  174.  Lascano D, Pak JS, Kates M, Finkelstein JB, Silva M, Hagen E, Roy Choudhury A, Bivalacqua TJ, DeCastro GJ, Benson MC, McKiernan JM. Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification tools. Urologic Oncology. 33:426.e1-426.e12, 2015.
  175.  Castiglione F, Bergamini A, Albersen M, Hannan JL, Bivalacqua TJ, Bettiga A, Benigni F, Salonia A, Montorsi F, Hedlund P. Pelvic nerve injury negatively impacts female genital blood flow and induces vaginal fibrosis-implications for human nerve-sparing radical hysterectomy. BJOG. 122:1457-65, 2015.
  176.  Baras AS, Gandhi N, Munari E, Faraj S, Shultz L, Marchionni L, Schoenberg M, Hahn N, Hoque O, Berman D, Bivalacqua TJ, Netto G. Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma. PLoS One.;10:e0143990, 2015.
  177.  Sokoll LJ, Zhang Z, Chan DW, Reese AC, Bivalacqua TJ, Partin AW, Walsh PC. Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy? Journal of Urology, (in press). 2015
  178.   Sopko NA, Matsui H, Hannan JL, Berkowitz D, Champion HC, Hsu LL, Musicki B, Burnett AL, Bivalacqua TJ. Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 Dysregulation. Journal of Sexual Medicine. 12:1878-85, 2015.
  179. Reis LO, Taheri D, Chaux A, Guner G, Mendoza Rodriguez MA, Bivalacqua TJ, Schoenberg MP, Epstein JI, Netto GJ. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder. Human Pathology. (in press), 2015.
  180.   Park JC, Gandhi NM, Carducci MA, Eisenberger MA, Baras AS, Netto GJ, Liu JJ, Drake CG, Schoenberg MP, Bivalacqua TJ, Hahn NM. A Retrospective Analysis of the Effect of Time from Diagnosis to Cystectomy on Survival in Patients with Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy. Journal of Urology (in press), 2015.
  181.  Baras A, Drake C, Liu JJ, Gandhi N, Kates M, Hoque MO, Meeker A, Hahn N, Taube JM, Schoenberg MP, Netto G, Bivalacqua TJ.  The ratio of CD8 to Treg Tumor Infiltrating Lymphocytes is Associated with Response to Cisplatin Based Neoadjuvant Chemotherapy in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder.  OncoImmunology (in press), 2015.
  182.   Chappidi MR, Kates M, Patel HD, Tosoian JT, Kaye DR, Sopko N, Lascano D, Liu JJ, Mckiernan J, Bivalacqua TJ.  Frailty as a Marker of Adverse Outcomes In Bladder Cancer Patients Undergoing Radical Cystectomy.  Urologic Oncology (in press), 2015. 
  183. Hyndman ME, Bivalacqua TJ, Mettee LZ, Su LM, Trock BJ, Pavlovich CP.  Nightly sildenafil use after radical prostatectomy has adverse effects on urinary convalescence: Results from a randomized trial of nightly vs on-demand dosing regimens.  Canadian Urologic Association Journal 9:414-419, 2015.
  184.   Althumairi AA, Canner JK, Gorin MA, Fang SH, Gearhart SL, Wick EC, Safar B, Bivalacqua TJ, Efron JE.    Reduction of Costs for Pelvic Exenteration Performed by High Volume Surgeons: Analysis of the Maryland Health Service Cost Review Commission Database.  American Surgery 82:46-52, 2016.
  185. Ball MW, Bezerra SM, Chaux A, Faraj SF, Gonzalez-Roibon N, Munari E, Sharma R, Bivalacqua TJ, Netto GJ, Burnett AL.  Overexpression of Insulin-like Growth Factor-1 Receptor is Associated with Penile Cancer Progression.  Urology (in press), 2016.
  186.   Zargar H, Zargar-Shoshtari K, Lotan Y, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black P; Collaborators.  Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1?   Journal of Urology (in press), 2016. 

EDUCATIONAL ACTIVITIES
Educational Publications
Review Articles

  1. W.J.G. Hellstrom and T.J. Bivalacqua.  Peyronie’s Disease:  Etiology, Medical, and Surgical Therapy.  Journal of Andrology 21:347-354, 2000. 
  2. T.J. Bivalacqua, H.C. Champion, W.J.G. Hellstrom, and P.J. Kadowitz.  Pharmacotherapy for Erectile Dysfunction.  Trends in Pharmacological Sciences 21:484-489, 2000.
  3. T.J. Bivalacqua, S.K. Purohit, and W.J.G. Hellstrom.  Peyronie’s Disease:  Advances in Basic Science and Pathophysiology.  Current Urology Reports 1:297-301, 2000.
  4. T.J. Bivalacqua and W.J.G. Hellstrom.  Potential Application of Gene Therapy in the Treatment of Erectile Dysfunction.  Journal of Andrology 22:183-190, 2001.
  5. T.J. Bivalacqua, H.C. Champion, and W.J.G. Hellstrom.  Implications of Nitric Oxide Synthase Isoforms in the Pathophysiology of Peyronie’s Disease.  International Journal of Impotence Research 14:345-352, 2002.
  6. T.J. Bivalacqua, H.C. Champion, M.F. Usta, P.J. Kadowitz, and W.J.G. Hellstrom.  Endothelial Dysfunction in Erectile Dysfunction: Role of the Endothelium in Erectile Physiology and Disease.  Journal of Andrology 24:S17-S37, 2003.
  7. M. Kendirci, T.J. Bivalacqua, and W.J.G. Hellstrom.  Vardenafil: A Novel Type 5 Phosphodiesterase Inhibitor for the Treatment of Erectile Dysfunction.  Expert Opinion in Pharmacotherapy 5:923-932, 2004. 
  8. B.A. Bunnell, W. Deng, C.M. Robinson, P.R. Waldron, T.J. Bivalacqua, S.R. Baber, P.J. Kadowitz. Potential Application of Mesenchymal Stem Cells for Treatment of Cardiovascular Diseases. Canadian Journal of Physiology and Pharmacology 83:529-539, 2005.
  9. T.J. Bivalacqua, B. Musicki, M.F. Usta, H.C. Champion, P.J. Kadowitz, A.L. Burnett, W.J.G. Hellstrom.  Endothelial Nitric Oxide Synthase Gene Therapy for Erectile Dysfunction.  Current Pharmaceutical Design 11:4059-4067, 2005. 
  10. W. Deng, T.J. Bivalacqua, W.J.G. Hellstrom, and P.J. Kadowitz.  Gene and Stem Cell Therapy for Erectile Dysfunction.  International Journal of Impotence Research 17:S57-S63, 2005
  11. A.L. Burnett, B. Musicki, L. Jin, and T.J. Bivalacqua. Nitric Oxide/Redox-Based Signaling a Therapeutic Target for Penile Disorders.  Expert Opinion in Therapeutic Targets 10:445-457, 2006.
  12. T.J. Bivalacqua and A.L. Burnett. Priapism:  New Concepts in the Pathophysiology and New Treatment Strategies.  Current Urology Reports 7:497-502, 2006.
  13. M. Kendirci, P.C. Teloken, H.C. Champion, W.J.G. Hellstrom, and T.J. Bivalacqua.  Gene Therapy for Erectile Dysfunction:  Fact or Fiction?  European Urology 50:1208-1222, 2006. 
  14. A.L. Burnett and T.J. Bivalacqua.  Priapism: Current Principles and Practice.  Urologic Clinics of North America 34:631-642, 2007.
  15. T.D. Strong, M.A. Gebska, A.L. Burnett, H.C. Champion, and T.J. Bivalacqua.  Endothelium-specific gene and stem cell-based therapy for erectile dysfunction.  Asian Journal of Andrology 10:14-22, 2008.
  16. T.J. Bivalacqua and T.D. Strong.  The Use of Gene Transfer Technology to Study the Pathophysiology of Erectile Dysfunction.  Journal of Sexual Medicine 5:268-275, 2008.
  17. T. D. Strong, H.C. Champion, A.L. Burnett and T.J. Bivalacqua.  Stem and Endothelial Progenitor Cells in Erectile Biology.  Internal Journal of Impotence Research 20:243-254, 2008.
  18. T.J. Guzzo, T.J. Bivalacqua, and M.P. Schoenberg.  Bladder Cancer and the Aluminum Industry:  A Review of the Literature.  BJU International 102:1058-1060, 2008.
  19. B. Musicki B, T. Liu, G.A. Lagoda, T.J. Bivalacqua, T.D. Strong, and A.L. Burnett.  Endothelial Nitric Oxide Synthase Regulation in Female Genital Tract Structures.  Journal of Sexual Medicine 6:247-253, 2009.
  20. T.J. Bivalacqua, P.M. Pierorazio, and L.M. Su. Open, Laparoscopic, and Robotic Radical Prostatectomy: Optimizing the Surgical Approach.  Surgical Oncology 18:233-241, 2009.
  21. Levey HR, Kutlu O, Bivalacqua TJ.  Medical Management of Ischemic Stuttering Priapism: A contemporary review of the literature.  Asian Journal of Andrology 14:156-163, 2012.
  22. Bivalacqua TJ, Musicki B, Kutlu O, Burnett AL.  New insights into the pathophysiology of sickle cell disease-associated priapism. Journal of Sexual Medicine 9:79-87, 2012.
  23. Bivalacqua TJ.  Metabolomics and Urologic Oncology.  Urologic Oncology 29:550, 2011.
  24. Hyndman ME, Mullins J, Bivalacqua TJ.  Metabolomics and Bladder Cancer.  Urologic Oncology 29:558-561, 2011.
  25. Hyndman ME, Kaye D, Field NC, Lawson KA, Smith ND, Steinberg GD, Schoenberg MP, Bivalacqua TJ. The use of regenerative medicine in the management of invasive bladder cancer. Advances in Urology (in press). 2012.
  26. Hakim L, Van der Aa F, Bivalacqua TJ, Hedlund P, Albersen M. Emerging tools for erectile dysfunction: a role for regenerative medicine. Nature Reviews in Urology 9:520-536, 2012.
  27. Albersen M, Bivalacqua TJ. Sexual dysfunction: First EAU priapism treatment guidelines published. Nature Reviews in Urology. 11:132-1134, 2014.\
  28. Sopko NA, Hannan JL, Bivalacqua TJ. Understanding and targeting the Rho-kinase pathway in erectile dysfunction. Nature Reviews in Urology. 11:622-628, 2014.
  29. Levey HR, Segal RL, Bivalacqua TJ. Management of priapism: an update for clinicians. Therapeutic Advances in Urology 6:230-44, 2014.
  30. Kaye DR, Mullins JK, Carter HB, Bivalacqua TJ. Robotic surgery in urological oncology: patient care or market share? Nature Reviews in Urology. 12:55-60, 2015.
  31. Sundi D, Svatek RS, Nielsen ME, Schoenberg MP, Bivalacqua TJ. Extent of pelvic lymph node dissection during radical cystectomy: is bigger better? Reviews in Urology. 16:159-66, 2014.
  32. Kates M, Singh A, Matsui H, Steinberg GD, Smith ND, Schoenberg MP, Bivalacqua TJ.  Tissue-engineered urinary conduits.  Current Urology Reports. 16:8-16, 2015.
  33. Weyne E, Castiglione F, Van der Aa F, Bivalacqua TJ, Albersen M. Landmarks in erectile function recovery after radical prostatectomy. Nature Reviews in Urology. 12:289-97, 2015.
  34. Matsui H, Sopko NA, Hannan JL, Bivalacqua TJ.   Mini Review: Pathophysiology of Erectile Dysfunction. Current Drug Targets. 16:411-9, 2015.
  35. Sopko NA, Kates M, Bivalacqua TJ. Use of regenerative tissue for urinary diversion. Current Opinions in Urology.  25:578-85, 2015. 
  36. Kates M, Sopko NA, Matsui H, Drake CG, Hahn NM, Bivalacqua TJ. Immune checkpoint inhibitors: a new frontier in bladder cancer. World Journal of Urology. 49-55, 2016.
  37. Musicki B, Bella AJ, Bivalacqua TJ, Davies KP, DiSanto ME, Gonzalez-Cadavid NF, Hannan JL, Kim NN, Podlasek CA, Wingard CJ, Burnett AL. Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction. Journal of Sexual Medicine 12:2233-55, 2015. 37. 
  38. Ghasemzadeh A, Bivalacqua TJ, Hahn NM, Drake CG.  New Stratagies in Bladder Cancer: A Second Coming for Immunotherapy.  Clinical Cancer Research 22:793-801, 2016. 

Editorials

  1. M.F. Usta, T.J. Bivalacqua, and W.J.G. Hellstrom.  Re: optimizing treatment for diabetes mellitus induced erectile dysfunction.  Journal of Urology 171:1638-1639, 2004. 
  2. T.D. Strong, H.C. Champion, P.J. Kadowitz, and T.J. Bivalacqua.  Re: Potential Differentiation of Human Mesenchymal Stem Cell Transplanted In Rat Corpus Cavernosum Toward Endothelial Or Smooth Muscle Cells.  International Journal of Impotence Research 19:530, 2007.
  3. Chow NH, Knowles M, Bivalacqua TJ. Urothelial carcinoma. Advances in Urology (in press), 2012.
  4. Reply: Anatomic Extent of Pelvic Lymph Node Dissection: Impact on Long-term Cancer-specific Outcomes in Men With Positive Lymph Nodes at Time of Radical Prostatectomy.  Urology. 2013 Sep;82:659.
  5. Reply: Castiglione F, Hedlund P, Van der Aa F, Bivalacqua TJ, Rigatti P, Van Poppel  H, Montorsi F, De Ridder D, Albersen M. Reply from Authors re: Ching-Shwun Lin, Tom F. Lue. Adipose-derived Stem Cells for the Treatment of Peyronie's Disease? European Urology 2013;63:561-2.
  6. Reply: Reese AC, Bivalacqua TJ, Schoenberg MP. The utility of an extensive postchemotherapy staging evaluation in patients receiving neoadjuvant chemotherapy for bladder cancer. Urology.2014;84:364.
  7. Tran PT, Bivalacqua TJ, Dicker AP. Adjuvant radiation for node-positive disease after prostatectomy: more good news, but who will listen? Journal of Clinical Oncology 10;32:3917-9, 2014.
  8. Weyne E, Bivalacqua TJ, Albersen M. Immunosympathectomy for Preservation of Erectile Function Following Cavernous Nerve Injury. European Urology. 67:727-8, 2015.
  9. Reply: Joice GA, Kates M, Bivalacqua TJ. Reply: Sickle Cell Disease in Priapism: Disparity in Care?  Urology. 86:78-9, 2015.

Book Chapters

  1. W.J.G. Hellstrom, T.J. Bivalacqua, P.J. Kadowitz and P.C. Doherty.  Type 3, 4 and 5 Phosphodiesterase Inhibitors Influence Penile Erection in the Cat.  In: 8th World Meeting  on  Impotence Research, Meuleman, E., Nijehot, G.L., and Vanderschueren, D. (eds.), pgs. 219-224, 1998. 
  2. T.J. Bivalacqua, H.C. Champion, P.J. Kadowitz, P.C. Doherty and W.J.G. Hellstrom.  Potentiation of Erectile Response by Combination of Prostaglandin E1 and Rolipram in the Cat. In: 8th World Meeting on Impotence Research.  Meuleman, E., Nijehot, G.L.,   and Vanderschueren, D. (eds.), pgs. 225-229, 1998. 
  3. H.C. Champion, D.G. Lambert, T.J. Bivalacqua, D.B. McNamara, and P.J. Kadowitz.  Comparison of the Inhibitory Actions of Angiotensin AT1 Receptor Antagonists in the Peripheral Vascular Bed.  In: Angiotensin II Receptor Blockade Physiological and Clinical Implications, Dhalla N.S., Zahradka P., Dixon I.M.C., Beamish R.E. (eds.), pgs. 65-86, 1998.   
  4. T.J. Bivalacqua, H.C. Champion, P.J. Kadowitz, and W.J.G. Hellstrom.  Nitric Oxide Effect on Penile Blood Flow and Lower Genitourinary Tract Function.  In:  Nitric Oxide and the Regulation of the Peripheral Circulation.  Kadowitz, P.J. and McNamara, D.B. (eds.), New York: Springer-Verlag NY, Inc., pgs. 286-301, 2000. 
  5. P.J. Kadowitz, A.L. Hyman, B.D. Nossaman, T. J. Bivalacqua, W.A. Murphy, D.H. Coy, D.B. McNamara, and H.C. Champion.  Cadiovascular Actions of Adrenomedullin.  In:  The CGRP Family: Calcitonin Gene-Related Peptide, Amylin, and Adrenomedullin.  Poyner D., Marshall, I, and Brain, S. (eds), Georgetown: Landes Biosecience, pgs. 115-122, 2000. 
  6. H.C. Champion, R.L. Pierce, T.J. Bivalacqua, W.A. Murphy, D.H. Coy, and P.J. Kadowitz. Analysis of Responses to hAmylin and hCGRP in Isolated Resistance Arteries from the Mesenteric Vascular Bed of the Rat.  In:  The CGRP Family: Calcitonin Gene-Related Peptide, Amylin, and Adrenomedullin.  Poyner D., Marshall, I, and Brain, S. (eds), Georgetown: Landes Biosecience, pgs. 189-190, 2000.
  7. H.C. Champion, T.J. Bivalacqua, R. Wang, W.J.G. Hellstrom, W.A. Murphy, D.H. Coy, and P.J. Kadowitz.  Effects of ADM and CGRP on Erectile Activity in the Cat.  In:  The CGRP Family: Calcitonin Gene-Related Peptide, Amylin, and Adrenomedullin.  Poyner D., Marshall, I, and Brain, S. (eds), Georgetown: Landes Biosecience, pgs. 199-201, 2000. 
  8. T.E. Novak, T.J. Bivalacqua, R. Davis, and W.J.G. Hellstrom.  Management of Erectile Dysfunction following Radical Prostatectomy.  In: Male Sexual Function: A Guide to   Clinical Management.  J.J. Mulcahy (ed), The Humana Press, Inc. pgs. 109-122, 2001.  
  9. T.J. Bivalacqua, M.F. Usta, and R. Wang.  Animal models for the study of erectile dysfunction. In: Sexual Dysfunctions. C. Teloken, C. Teodosio Da Ros, M. Tannhauser (eds), Brazile publisher, pgs. 34-38, 2004.
  10. M.F. Usta, T.J. Bivalacqua, and W.J.G. Hellstrom.  Peyronie’s Disease.  In: Sexual Dysfunctions. C. Teloken, C. Teodosio Da Ros, M. Tannhauser (eds), Brazile publisher, pgs. 214-221, 2004. 
  11. K. McKenna, T.J. Bivalacqua, M. Baum, L. Coolen, P. Hedlund, K. Park, E. Pescatori, J. Rajfer, and Y. Sato.  Experimental Studies of Sexual Functions and Dysfunctions Including Brain Imaging Studies.  In: Erectile Dysfunction T.F. Lue, R. Basson, F. Giuliano, F. Montorsi, R. Rosen (eds), World Health Organization, Paris, France, 2004.
  12.   T.J. Bivalacqua and M. Allaf.  Erectile Dysfunction and Peyronie’s Disease.  In: The Brady Urology Manual, J.K. Parsons, E.J. Wright (eds), pgs. 51-62, 2006.
  13. M. Allaf and T.J. Bivalacqua.  Priapism.  In: The Brady Urology Manual, J.K. Parsons, E.J. Wright (eds), pgs. 273-278, 2006.
  14. T.J. Bivalacqua, T.D. Strong, H.C. Champion, and A.L. Burnett.  Stem and Endothelial Progenitor Cells in Erectile Biology:  Future Therapeutic Applications and Potential Biomarker for ED.  In: Textbook of Erectile Dysfunction, 2nd Edition; Carson, Kirby, Goldstein, Wyllie (eds), (in press), 2009.
  15. T.J. Bivalacqua, B. Musicki, H.C. Champion, and A.L. Burnett.  Phosphodiesterase Type 5 Inhibitor Therapy for Priapism.  In: Textbook of Erectile Dysfunction, 2nd Edition; Carson, Kirby, Goldstein, Wyllie (eds), (in press), 2009.
  16.   T.J. Bivalacqua, and A.L. Burnett.  Operations for Priapism.  In:  Hinman’s Atlas of Urologic Surgery, 3rd Edition; Resnick, McGuire, Howards, Preminger, Smith (eds), (in press), 2009.
  17. T.J. Bivalacqua, and A.L. Burnett.  Priapism.  In: Glenn’s Urologic Surgery, 7th Edition; Graham and Keane (eds), pgs 487-492, 2010.A. Schaeffer, and T.J. Bivalacqua.  Erectile Dysfunction.  In: 5 Minute Urology Consult;  Gomella (ed),  pgs 118-119, 2010.
  18. A. Schaeffer, and T.J. Bivalacqua.  Erectile Dysfunction.  In: 5 Minute Urology Consult; Gomella (ed),  pgs 118-119, 2010.
  19.   A. Schaeffer, and T.J. Bivalacqua.  Peyronie’s Disease.  In: 5 Minute Urology Consult; Gomella (ed), pgs 256-257, 2010.
  20.   A. Schaeffer, and T.J. Bivalacqua.  Urinary Tract Infection in Men.  In: 5 Minute Urology Consult;  Gomella (ed), pgs 508-509, 2010.
  21.   T. Lally, Burnett AL, and T.J. Bivalacqua.  Scleroderma and Erectile Dysfunction.  In: Scleroderma: From Pathogenesis to Comprehensive Management; Varga, Denton, Wigley (eds) (in press), 2012.


Memberships


  • Member, American Society of Andrology
  • Member, Sexual Medicine Society of North America, Inc.
  • Member, International Society of Sexual Medicine
  • Member, American Urologic Association (AUA)
  • Member, Endourological Society
  • Member, Alpha Omega Alpha (AOA)
  • Member, Society for Basic Urologic Research (SBUR)
  • Member, Society of Urologic Oncology (SUO)


Awards & Honors


1999 Thomas S.K. Change Trainee Award – American Society of Andrology
2000 1st Prize Essay Contest: Society for the Study of Impotence         
2001 3rd Prize Montague Boyd Essay Contest: Southeastern Section AUA
2001-02 Basic Research Award in Integrated Biology: Tulane Health Research Day
2001 Jorgen U. Schlegel Award for Excellence in Research, Tulane School of Medicine
2002 Jean François Ginestíe Prize: Best Paper on Basic Science of Sexual Medicine
2003 Best Basic Science Abstract: Sexual Medicine Society of North America, Inc.
2004 American Federation for Medical Research Student Recognition Award
2004 John T. Halsey Award, Tulane School of Medicine
2004 Joseph Hume Memorial Award, Tulane School of Medicine
2004 AUA/Yamanouchi Best Abstract Prize: Impotence
2004 Outstanding Surgical Intern, Johns Hopkins University, Department of Surgery
2004 Arnold M Seligman Award for Most Outstanding Surgical Resident, Sinai Hospital of Baltimore
2005 Best Basic Science Abstract: Sexual Medicine Society of North America, Inc.
2006 Zorgniotti-Newman Prize (Co-author): Best Clinical Research in Sexual Medicine
2007 Alpha Omega Alpha, Johns Hopkins University, Elected as House Officer
2007 1st Prize Resident Essay Contest:  Laboratory Science, Mid-Atlantic Section AUA 
2007 Best Basic Science Abstract:  Sexual Medicine Society of North America, Inc.
2007-08 American Urological Association Foundation Astellas USA Foundation MD/PhD Fellowship
2008 Jack Lapides Neurourology Essay Contest Grand Prize Winner
2008 2nd Prize Resident Essay Contest:  Laboratory Science, America Urological Association
2008 Cook Urology Travel Award from American Society of Andrology
2008 American Society of Andrology Trainee Award
2008 Outstanding Graduate: AUA Foundation           
2008 Young Investigator Award AUA Research Forum   
2010 Young Investigator Award Society of Basic Urologic Research (SBUR)
2011 Best Poster, Basic Science; American Urological Association (AUA) Annual Meeting
2012

American Urological Association (AUA) Foundation Rising Star in Urology Research Award
2013

Best Poster, Basic Science ED; American Urological Association (AUA) Annual Meeting.
2014 Best Poster, Bladder Cancer: Invasive; American Urological Association (AUA) Annual Meeting.
2014

1st Prize Best Abstract Non-Oncology, European Association of Urology (EAU) Annual Meeting.